FTRD application in 56 patients with lesions in the upper GI tract showed a technical success rate of 93 %, a R0-resection rate of 68 % and only mild to moderate adverse ...
Rolling submission to accelerate time to marketing authorization of CVnCoV in Switzerland
Review process started with submission of first CVnCoV data package
...
COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rollin...
On April 14th, 65 participants from the fields of clinics, research, software development and medical technology came together to get to know AIQNET and the partners involved better.
Charité – Universitätsmedizin Berlin, Germany, enrolls first patient in Phase II study to assess oral treatment ATR-002
RESPIRE1 is a placebo-controlled, inter...
Olaf Althaus appointed Chief Financial Officer
Stephan Stenglein, M.D., recently joined as Chief Medical Officer
Proven track record and 20+ years of experience in their respective fields of ex...
(Stuttgart) - Insilico Biotechnology AG and 2-control ApS are joining forces to take another important step towards the Smart Biofactory. The aim of the collaboration is ...
First challenge infection study in preclinical mouse model to provide evidence for protection against SARS-CoV-2 variant
CVnCoV induces robust antibody titers with v...
Impact of new SARS-CoV-2 variants supports specification of select strains for anticipated case-driven interim analysis in pivotal Phase 2b/3 study
Progress in Phase...
On March 12th, 2021, an online round table with Sanofi took place in the context of the project Codex4SMEs (Companion Diagnostics expedited for small and medium-sized enterprises).
...
Company to host conference call on Wednesday, March 17 at 8:30 am EST
First anti-tumor activity observed in heavily pre-treated solid cancer patients during early p...
Novartis plans to start manufacturing of the mRNA and bulk drug product of CureVac’s COVID-19 vaccine candidate, CVnCoV, in Q2 2021
Anticipated production of up to 5...
Evaluation of the “German colonic FTRD registry” comprising 1178 colorectal FTRD procedures from 65 centers of different care levels demonstrated technical success in 88....
(Stuttgart) - Insilico Biotechnology AG and Meyer Chroma Technology (MCT) announce joining forces to provide the biopharma industry with an eco-system of Digital Twins en...
A prospective multicenter study analyzing the data of the Dutch colorectal eFTR registry comprising 367 EFTR procedures shows a technical success rate of 83.9 % and a R0 ...
Rolling submission with EMA initiated to accelerate time to potential marketing authorization of CVnCoV
Submission of CVnCoV pre-clinical data package marks start of...
It may have something of an obscure and unassuming title, but the Digital Healthcare Act (Digitale-Versorgung-Gesetz) makes Germany the first country in the world to intr...
Colonic OTSC placement was mostly performed in patients undergoing polypectomy (62.4 %), but also for closure of iatrogenic perforations (15.8 %), colonic bleeding (10.1 ...
Biomolecules from renewable raw materials for the textile industry
Textiles can be coated with the biopolymer chitosan and thus made water-repellent by binding hydrophobic molecules. The good thing...
Building an integrated European vaccine manufacturing network with experienced partners
Managing supply chain risk by collaborating with several partners for each ma...
